Literature DB >> 19893779

Ross River virus.

Bridget Barber1, Justin T Denholm, Denis Spelman.   

Abstract

BACKGROUND: Ross River virus is Australia's most common and widespread arbovirus. It causes epidemic polyarthritis and is associated with significant morbidity and cost to society.
OBJECTIVE: This article aims to increase clinicians' awareness of the epidemiological and clinical features of Ross River virus and provide information regarding prevention, diagnosis and management. DISCUSSION: Ross River virus occurs throughout Australia and numerous outbreaks have occurred. Most cases occur in northern Australia during the wet season, and individuals with high exposure to mosquitoes are most at risk. Arthralgia is the most common presenting symptom and is usually associated with rash, fever and lethargy. No treatment alters the course of the illness, although patients may benefit from simple analgesics or nonsteroidal anti-inflammatory drugs. Symptoms usually resolve within 6 months. Personal protective measures against mosquitoes are an important prevention strategy.

Entities:  

Mesh:

Year:  2009        PMID: 19893779

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  7 in total

1.  Identification of Natural Molecular Determinants of Ross River Virus Type I Interferon Modulation.

Authors:  Adam Taylor; Suresh Mahalingam; Xiang Liu; Margit Mutso; Liubov Cherkashchenko; Eva Zusinaite; Lara J Herrero; Stephen L Doggett; John Haniotis; Andres Merits; Belinda L Herring
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

Review 2.  Zika Virus.

Authors:  Didier Musso; Duane J Gubler
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

Review 3.  Vectors and vector-borne diseases of horses.

Authors:  A C Onmaz; R G Beutel; K Schneeberg; A N Pavaloiu; A Komarek; R van den Hoven
Journal:  Vet Res Commun       Date:  2012-09-30       Impact factor: 2.816

4.  Osteoblasts from osteoarthritis patients show enhanced susceptibility to Ross River virus infection associated with delayed type I interferon responses.

Authors:  Weiqiang Chen; Suan-Sin Foo; Rachel W Li; Paul N Smith; Suresh Mahalingam
Journal:  Virol J       Date:  2014-11-19       Impact factor: 4.099

5.  Pentosan polysulfate sodium for Ross River virus-induced arthralgia: a phase 2a, randomized, double-blind, placebo-controlled study.

Authors:  Lara J Hererro; Paul Griffin; Ravi Krishnan; Melanie Duiker; Penny A Rudd; Donna Skerrett; James G D Pollard; Carolyn Siddel; Rifat Rifat; Jennifer H K Ng; Peter Georgius
Journal:  BMC Musculoskelet Disord       Date:  2021-03-12       Impact factor: 2.362

6.  TIR-Domain-Containing Adapter-Inducing Interferon-β (TRIF)-Dependent Antiviral Responses Protect Mice against Ross River Virus Disease.

Authors:  Xiang Liu; Adam Taylor; Yee Suan Poo; Wern Hann Ng; Lara J Herrero; Patrick Chun Hean Tang; Ali Zaid; Suresh Mahalingam
Journal:  mBio       Date:  2022-01-04       Impact factor: 7.867

7.  Optimising predictive modelling of Ross River virus using meteorological variables.

Authors:  Iain S Koolhof; Simon M Firestone; Silvana Bettiol; Michael Charleston; Katherine B Gibney; Peter J Neville; Andrew Jardine; Scott Carver
Journal:  PLoS Negl Trop Dis       Date:  2021-03-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.